Animal Health - Session 2: Clinical Studies - A European Perspective

e-learning
In this presentation, we look at changes brought in with Regulation 2019/6 impacting clinical studies.

Are you ready for the new veterinary Regulation?

Implementation of the new veterinary medicines regulation in the EU (Regulation 2019/6, or the new VMP-Reg) is imminent: the Regulation will come into force on January 28th, 2022.

For two decades, the EU legislation around veterinary medicines has remained largely the same; clarifications have been made of certain scientific and legal aspects of Directive 2001/82 EC as amended, and the associated legislation and guidelines – but essential principles have not changed during this time. The new VMP-Reg represents a significant departure from the ‘old’ legislation for all of us - from Marketing Authorisation Holders to manufacturers, from regulatory affairs strategists to clinical study monitors.

The Animal Health Team at knoell have prepared this series of e-learnings, providing expert insights into the content of the new VMP-Reg from different perspectives and within different contexts.

In this presentation, we look at changes brought in with Regulation 2019/6 impacting clinical studies, with a general overview and background on the topic from a knoell perspective:

  • Impact of Regulation 2019/6 on clinical studies
  • Profile of a Clinical studies team: knoell Animal Health
  • Pre-Clinical Studies
  • Quality Assurance
  • Useful contacts

Don’t forget to check back later in the spring of 2022, when we will publish the next e-learnings in this series!

Interested in latest news on Animal Health Regulations? Click here!

Details

Target audience
Marketing Authorisation Holders, Manufacturers, Importers, Distributors and Regulatory Affairs professionals all in the field of veterinary medicines, specifically vet pharmaceuticals.
Language
English